Intra-Cellular Therapies, Inc.

Bank of New York Mellon Corp

Report date

3/31/2025

Quarter

2025 Q1

Filed

4/29/2025

Shares

350,044

Value ($000)

46,178

Weight

0.0%

2019 Q4 - 2025 Q1 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	4/29/2025	46,178	0.0%	350,044	3/31/2025
2024 Q4	2/4/2025	29,987	0.0%	359,045	12/31/2024
2024 Q3	11/12/2024	25,662	0.0%	350,715	9/30/2024
2024 Q2	7/25/2024	23,913	0.0%	349,148	6/30/2024
2024 Q1	4/25/2024	26,038	0.0%	376,271	3/31/2024
2023 Q4	1/29/2024	29,743	0.0%	415,284	12/31/2023
2023 Q3	10/24/2023	21,061	0.0%	404,329	9/30/2023
2023 Q2	8/3/2023	25,211	0.0%	398,147	6/30/2023
2023 Q1	5/9/2023	20,977	0.0%	387,384	3/31/2023
2022 Q4	2/14/2023	20,573	0.0%	388,766	12/31/2022
2022 Q3	11/14/2022	18,080	0.0%	388,559	9/30/2022
2022 Q2	8/15/2022	21,884	0.0%	383,388	6/30/2022
2022 Q1	5/11/2022	23,591	0.0%	385,508	3/31/2022
2021 Q4	2/11/2022	19,183	0.0%	366,509	12/31/2021
2021 Q3	11/18/2021	12,872	0.0%	345,291	9/30/2021
2021 Q2	8/11/2021	13,542	0.0%	331,744	6/30/2021
2021 Q1	5/13/2021	10,347	0.0%	304,956	3/31/2021
2020 Q4	2/9/2021	9,295	0.0%	292,312	12/31/2020
2020 Q3	11/12/2020	7,992	0.0%	311,506	9/30/2020
2020 Q2	8/12/2020	6,422	0.0%	250,170	6/30/2020
2020 Q1	5/6/2020	3,566	0.0%	232,027	3/31/2020
2019 Q4	2/14/2020	6,480	0.0%	188,881	12/31/2019